activates MAP kinase
and Elk-1 through a B-Raf- and Rap1-dependent
pathway. Cell, 89(1), 73-82 (1997).
4. Lasater, E. M., and Liu, Y., J. Neurophysiology,
71, 743-752 (1994).
5. Ogreid, D.
, 3(3-4), 173-181 (1993).
5. Edelstein, P. H., and Edelstein, M. A., Comparison
of three buffers used in the formulation of buffered
charcoal yeast extract medium. J. Clin. Microbiol.,
31(12), 3329
toxin K9: localization versus Phosphorylation".
Université de Toulouse, Ph.D. dissertation, p. 73
(2015).
21. Andersen, Tor Kristian, "APC-targeted DNA
vaccines against pandemic influenza". University
Pharmacol Sci., 35, 178-86
(2014).
12. Wolf HK. and Dittrich KL., J. Histochem.
Cytochem., 40, 1269-73 (1992)
DR_OKF/LV,SG,PHC 09/16-1
2016 Sigma-Aldrich Co. LLC. All rights reserved
(1979).
2. Cuello, A., Br. Med. Bull., 39, 11 (1983).
5391 (1993).
4. Lazarus, L., et al., Proc. Natl. Acad. Sci. USA, 73,
2156 (1976).
5. Liotta, A., et al., Proc. Natl. Acad. Sci. USA, 75